Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Lateral Crow's Feet: Double-Blind, Placebo-Controlled, Dose-Ranging Study
β Scribed by BENJAMIN ASCHER; BERTHOLD J. RZANY; RAJIV GROVER
- Book ID
- 109076835
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 510 KB
- Volume
- 35
- Category
- Article
- ISSN
- 1076-0512
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Drooling is a frequent symptom in Parkinson's disease (PD), occurring in almost 75% of all patients. Although it is now well known that drooling in PD is the result of swallowing difficulties rather than excessive saliva production, few treatments have been developed to reduce it. Clini
## Abstract Botulinum toxin type A (Dysport) has been shown in European studies to be a safe and effective treatment for cervical dystonia. This multicenter, doubleβblind, randomized, controlled trial assessed the safety and efficacy of Dysport in cervical dystonia patients in the United States. Ei